Project
GNF SymAtlas + NCI-60 cancer cell lines, human (Su, 2004; Ross, 2000)
Navigation
Downloads
Results for MLXIPL
Z-value: 1.27
Motif logo
Transcription factors associated with MLXIPL
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
MLXIPL
|
ENSG00000009950.16 | MLXIPL |
Activity-expression correlation:
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| MLXIPL | hg38_v1_chr7_-_73624492_73624549 | 0.48 | 1.0e-13 | Click! |
Activity profile of MLXIPL motif
Sorted Z-values of MLXIPL motif
Network of associatons between targets according to the STRING database.
First level regulatory network of MLXIPL
Gene Ontology Analysis
Gene overrepresentation in biological process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.2 | 24.9 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
| 4.2 | 12.5 | GO:0071848 | circadian temperature homeostasis(GO:0060086) regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 3.8 | 19.0 | GO:1902847 | regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
| 3.0 | 9.1 | GO:0030451 | regulation of complement activation, alternative pathway(GO:0030451) negative regulation of complement activation, alternative pathway(GO:0045957) |
| 2.8 | 8.5 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
| 2.7 | 8.2 | GO:1902595 | regulation of DNA replication origin binding(GO:1902595) |
| 2.5 | 19.8 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 2.4 | 9.6 | GO:1902530 | regulation of protein linear polyubiquitination(GO:1902528) positive regulation of protein linear polyubiquitination(GO:1902530) |
| 2.4 | 7.1 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
| 2.3 | 2.3 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
| 2.3 | 6.8 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 2.1 | 6.4 | GO:2001153 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
| 2.0 | 5.9 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) double-strand break repair involved in meiotic recombination(GO:1990918) |
| 2.0 | 7.9 | GO:0031627 | telomeric loop formation(GO:0031627) |
| 1.9 | 13.5 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 1.9 | 5.7 | GO:0018094 | protein polyglycylation(GO:0018094) |
| 1.9 | 5.7 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
| 1.9 | 5.7 | GO:0001978 | regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback(GO:0001978) baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
| 1.8 | 5.3 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 1.7 | 5.2 | GO:0036292 | DNA rewinding(GO:0036292) |
| 1.7 | 1.7 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
| 1.7 | 15.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
| 1.7 | 6.8 | GO:0072166 | posterior mesonephric tubule development(GO:0072166) negative regulation of metanephric glomerulus development(GO:0072299) negative regulation of metanephric glomerular mesangial cell proliferation(GO:0072302) |
| 1.7 | 6.7 | GO:0086053 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 1.6 | 3.2 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
| 1.6 | 6.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
| 1.5 | 6.0 | GO:0046968 | peptide antigen transport(GO:0046968) |
| 1.5 | 4.5 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
| 1.5 | 4.5 | GO:0043012 | regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 1.5 | 4.5 | GO:0038156 | interleukin-3-mediated signaling pathway(GO:0038156) |
| 1.5 | 4.5 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 1.5 | 5.9 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
| 1.5 | 8.7 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
| 1.5 | 4.4 | GO:0045643 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) |
| 1.4 | 2.9 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
| 1.4 | 10.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
| 1.4 | 4.3 | GO:0009386 | translational attenuation(GO:0009386) |
| 1.4 | 4.2 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
| 1.4 | 18.1 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) |
| 1.4 | 22.2 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
| 1.4 | 2.8 | GO:0090291 | negative regulation of osteoclast proliferation(GO:0090291) |
| 1.4 | 99.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
| 1.4 | 4.1 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 1.3 | 25.5 | GO:0015671 | oxygen transport(GO:0015671) |
| 1.3 | 8.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
| 1.3 | 9.3 | GO:0072757 | cellular response to camptothecin(GO:0072757) |
| 1.3 | 3.9 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
| 1.3 | 3.9 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
| 1.3 | 3.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
| 1.3 | 6.3 | GO:0038170 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 1.2 | 3.7 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
| 1.2 | 11.9 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
| 1.2 | 1.2 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 1.2 | 3.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
| 1.2 | 10.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 1.2 | 5.8 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
| 1.1 | 50.3 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 1.1 | 2.3 | GO:1901563 | response to camptothecin(GO:1901563) |
| 1.1 | 4.5 | GO:0060611 | positive regulation of odontogenesis of dentin-containing tooth(GO:0042488) mammary gland fat development(GO:0060611) positive regulation of macrophage colony-stimulating factor signaling pathway(GO:1902228) positive regulation of response to macrophage colony-stimulating factor(GO:1903971) positive regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903974) positive regulation of microglial cell migration(GO:1904141) |
| 1.1 | 3.4 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 1.1 | 1.1 | GO:0009397 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
| 1.1 | 4.4 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
| 1.1 | 3.3 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
| 1.1 | 3.3 | GO:0035915 | pore formation in membrane of other organism(GO:0035915) |
| 1.1 | 3.2 | GO:0002590 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) negative regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002590) |
| 1.0 | 4.1 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
| 1.0 | 3.1 | GO:0019075 | virus maturation(GO:0019075) |
| 1.0 | 11.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
| 1.0 | 3.0 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
| 1.0 | 3.0 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
| 1.0 | 3.9 | GO:0003330 | regulation of extracellular matrix constituent secretion(GO:0003330) positive regulation of extracellular matrix constituent secretion(GO:0003331) |
| 1.0 | 3.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 1.0 | 4.9 | GO:0001555 | oocyte growth(GO:0001555) regulation of progesterone secretion(GO:2000870) |
| 1.0 | 3.9 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 1.0 | 3.9 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
| 1.0 | 1.9 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
| 1.0 | 3.8 | GO:0051037 | regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.9 | 5.7 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.9 | 2.8 | GO:0010808 | positive regulation of synaptic vesicle priming(GO:0010808) |
| 0.9 | 4.6 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
| 0.9 | 3.7 | GO:0015855 | pyrimidine nucleobase transport(GO:0015855) purine nucleobase transmembrane transport(GO:1904823) |
| 0.9 | 4.5 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
| 0.9 | 4.5 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
| 0.9 | 2.7 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
| 0.9 | 3.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
| 0.9 | 2.6 | GO:0060005 | vestibular reflex(GO:0060005) |
| 0.9 | 4.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
| 0.9 | 2.6 | GO:0030573 | bile acid catabolic process(GO:0030573) |
| 0.9 | 5.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.8 | 2.5 | GO:1903567 | negative regulation of protein localization to cilium(GO:1903565) regulation of protein localization to ciliary membrane(GO:1903567) negative regulation of protein localization to ciliary membrane(GO:1903568) |
| 0.8 | 1.7 | GO:0034699 | response to luteinizing hormone(GO:0034699) cellular response to luteinizing hormone stimulus(GO:0071373) |
| 0.8 | 11.9 | GO:0042574 | retinal metabolic process(GO:0042574) |
| 0.8 | 5.1 | GO:0035524 | proline transmembrane transport(GO:0035524) |
| 0.8 | 3.4 | GO:0021759 | globus pallidus development(GO:0021759) |
| 0.8 | 4.2 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.8 | 5.8 | GO:0018095 | protein polyglutamylation(GO:0018095) |
| 0.8 | 4.9 | GO:0008218 | bioluminescence(GO:0008218) |
| 0.8 | 5.7 | GO:0046549 | retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.8 | 13.8 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.8 | 4.0 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
| 0.8 | 4.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.8 | 8.0 | GO:0001766 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.8 | 3.2 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
| 0.8 | 2.4 | GO:2000661 | positive regulation of interleukin-1-mediated signaling pathway(GO:2000661) |
| 0.8 | 2.4 | GO:1990168 | protein K33-linked deubiquitination(GO:1990168) |
| 0.8 | 1.6 | GO:0002544 | chronic inflammatory response(GO:0002544) |
| 0.8 | 2.3 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
| 0.8 | 7.8 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.8 | 2.3 | GO:0061760 | antifungal innate immune response(GO:0061760) |
| 0.8 | 2.3 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
| 0.8 | 2.3 | GO:0051710 | regulation of cytolysis in other organism(GO:0051710) |
| 0.8 | 6.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
| 0.8 | 4.6 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.8 | 6.8 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.8 | 2.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
| 0.8 | 2.3 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
| 0.7 | 2.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
| 0.7 | 4.4 | GO:1903564 | regulation of protein localization to cilium(GO:1903564) |
| 0.7 | 5.2 | GO:0043587 | tongue morphogenesis(GO:0043587) |
| 0.7 | 11.0 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.7 | 2.9 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
| 0.7 | 2.9 | GO:0002331 | pre-B cell differentiation(GO:0002329) pre-B cell allelic exclusion(GO:0002331) |
| 0.7 | 2.9 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.7 | 3.6 | GO:0044245 | polysaccharide digestion(GO:0044245) |
| 0.7 | 4.3 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.7 | 4.2 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing by siRNA(GO:0090625) mRNA cleavage involved in gene silencing(GO:0098795) |
| 0.7 | 20.5 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
| 0.7 | 4.2 | GO:0007000 | nucleolus organization(GO:0007000) |
| 0.7 | 8.4 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
| 0.7 | 2.1 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
| 0.7 | 0.7 | GO:0072054 | renal inner medulla development(GO:0072053) renal outer medulla development(GO:0072054) |
| 0.7 | 2.1 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
| 0.7 | 2.7 | GO:1902159 | regulation of cyclic nucleotide-gated ion channel activity(GO:1902159) |
| 0.7 | 2.0 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.7 | 13.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
| 0.7 | 5.4 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
| 0.7 | 2.7 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
| 0.7 | 8.7 | GO:0060992 | response to fungicide(GO:0060992) |
| 0.7 | 2.0 | GO:0071878 | negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.7 | 5.3 | GO:0015886 | heme transport(GO:0015886) |
| 0.7 | 2.6 | GO:0090299 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of neural crest formation(GO:0090299) negative regulation of neural crest formation(GO:0090301) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000314) |
| 0.7 | 2.0 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) |
| 0.7 | 2.6 | GO:1903860 | negative regulation of dendrite extension(GO:1903860) regulation of neuron remodeling(GO:1904799) negative regulation of neuron remodeling(GO:1904800) negative regulation of branching morphogenesis of a nerve(GO:2000173) |
| 0.7 | 4.6 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
| 0.7 | 7.2 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
| 0.6 | 7.8 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.6 | 2.6 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.6 | 3.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
| 0.6 | 1.9 | GO:0002876 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
| 0.6 | 10.8 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
| 0.6 | 8.9 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
| 0.6 | 1.9 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
| 0.6 | 5.6 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.6 | 2.5 | GO:0071110 | protein biotinylation(GO:0009305) histone biotinylation(GO:0071110) |
| 0.6 | 4.9 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.6 | 9.2 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
| 0.6 | 3.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
| 0.6 | 1.8 | GO:0071206 | establishment of protein localization to juxtaparanode region of axon(GO:0071206) |
| 0.6 | 13.0 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
| 0.6 | 0.6 | GO:0097267 | omega-hydroxylase P450 pathway(GO:0097267) |
| 0.6 | 1.7 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
| 0.6 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.6 | 2.3 | GO:0002215 | defense response to nematode(GO:0002215) |
| 0.6 | 2.3 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
| 0.6 | 2.3 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.6 | 8.9 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
| 0.6 | 1.7 | GO:0035634 | response to stilbenoid(GO:0035634) |
| 0.6 | 1.7 | GO:0043605 | cellular amide catabolic process(GO:0043605) |
| 0.5 | 4.9 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.5 | 1.6 | GO:2001025 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) positive regulation of response to drug(GO:2001025) |
| 0.5 | 6.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
| 0.5 | 3.2 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
| 0.5 | 1.6 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.5 | 6.5 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
| 0.5 | 3.2 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.5 | 1.1 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
| 0.5 | 1.6 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
| 0.5 | 1.6 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
| 0.5 | 5.3 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
| 0.5 | 4.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.5 | 8.0 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
| 0.5 | 3.2 | GO:0045023 | G0 to G1 transition(GO:0045023) |
| 0.5 | 1.6 | GO:0001554 | luteolysis(GO:0001554) |
| 0.5 | 1.6 | GO:0045212 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.5 | 41.2 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
| 0.5 | 2.6 | GO:1903625 | negative regulation of DNA catabolic process(GO:1903625) |
| 0.5 | 9.2 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
| 0.5 | 0.5 | GO:0016078 | tRNA catabolic process(GO:0016078) |
| 0.5 | 2.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
| 0.5 | 2.0 | GO:0036378 | calcitriol biosynthetic process from calciol(GO:0036378) |
| 0.5 | 5.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.5 | 1.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.5 | 13.3 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
| 0.5 | 3.4 | GO:0070560 | protein secretion by platelet(GO:0070560) |
| 0.5 | 4.4 | GO:0035897 | proteolysis in other organism(GO:0035897) |
| 0.5 | 1.0 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
| 0.5 | 1.9 | GO:1905229 | cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.5 | 1.9 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.5 | 1.5 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
| 0.5 | 4.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
| 0.5 | 1.9 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
| 0.5 | 3.4 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
| 0.5 | 2.4 | GO:0016240 | autophagosome docking(GO:0016240) |
| 0.5 | 1.4 | GO:0051877 | pigment granule aggregation in cell center(GO:0051877) |
| 0.5 | 7.0 | GO:1990573 | potassium ion import across plasma membrane(GO:1990573) |
| 0.5 | 1.9 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.5 | 3.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.5 | 1.9 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
| 0.5 | 2.8 | GO:0003190 | atrioventricular valve formation(GO:0003190) |
| 0.5 | 1.4 | GO:0032328 | alanine transport(GO:0032328) |
| 0.5 | 10.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.5 | 1.8 | GO:0072092 | ureteric bud invasion(GO:0072092) |
| 0.5 | 3.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
| 0.5 | 3.2 | GO:0014827 | intestine smooth muscle contraction(GO:0014827) |
| 0.5 | 1.8 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
| 0.5 | 4.5 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.5 | 1.4 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
| 0.5 | 0.5 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
| 0.4 | 6.6 | GO:0034162 | toll-like receptor 9 signaling pathway(GO:0034162) |
| 0.4 | 3.5 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.4 | 4.0 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
| 0.4 | 8.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
| 0.4 | 4.3 | GO:0046958 | nonassociative learning(GO:0046958) |
| 0.4 | 1.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) maintenance of organ identity(GO:0048496) |
| 0.4 | 2.1 | GO:0034959 | substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
| 0.4 | 12.8 | GO:0015695 | organic cation transport(GO:0015695) |
| 0.4 | 3.4 | GO:0055129 | proline biosynthetic process(GO:0006561) L-proline biosynthetic process(GO:0055129) |
| 0.4 | 8.8 | GO:0002031 | G-protein coupled receptor internalization(GO:0002031) |
| 0.4 | 4.6 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.4 | 3.8 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
| 0.4 | 4.2 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.4 | 3.8 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.4 | 3.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.4 | 2.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
| 0.4 | 4.1 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
| 0.4 | 2.4 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
| 0.4 | 1.2 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
| 0.4 | 1.2 | GO:0018377 | protein myristoylation(GO:0018377) |
| 0.4 | 1.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.4 | 8.0 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
| 0.4 | 3.2 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
| 0.4 | 1.2 | GO:0000103 | sulfate assimilation(GO:0000103) |
| 0.4 | 0.4 | GO:0032423 | regulation of mismatch repair(GO:0032423) positive regulation of mismatch repair(GO:0032425) |
| 0.4 | 0.8 | GO:0072312 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
| 0.4 | 1.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.4 | 4.4 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
| 0.4 | 3.5 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.4 | 11.7 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.4 | 11.7 | GO:0007140 | male meiosis(GO:0007140) |
| 0.4 | 2.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
| 0.4 | 1.2 | GO:0051794 | negative regulation of transforming growth factor beta2 production(GO:0032912) catagen(GO:0042637) negative regulation of hair follicle maturation(GO:0048817) regulation of catagen(GO:0051794) regulation of melanosome transport(GO:1902908) |
| 0.4 | 2.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
| 0.4 | 3.0 | GO:0015705 | iodide transport(GO:0015705) |
| 0.4 | 0.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
| 0.4 | 3.8 | GO:0071265 | L-methionine biosynthetic process(GO:0071265) |
| 0.4 | 1.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
| 0.4 | 3.7 | GO:0042355 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
| 0.4 | 3.0 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
| 0.4 | 3.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
| 0.4 | 1.9 | GO:0051970 | negative regulation of transmission of nerve impulse(GO:0051970) |
| 0.4 | 1.9 | GO:0015793 | glycerol transport(GO:0015793) |
| 0.4 | 1.1 | GO:0061698 | protein demalonylation(GO:0036046) peptidyl-lysine demalonylation(GO:0036047) protein desuccinylation(GO:0036048) peptidyl-lysine desuccinylation(GO:0036049) protein deglutarylation(GO:0061698) peptidyl-lysine deglutarylation(GO:0061699) |
| 0.4 | 1.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
| 0.4 | 1.1 | GO:0071529 | cementum mineralization(GO:0071529) |
| 0.4 | 0.4 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
| 0.4 | 12.4 | GO:0060384 | innervation(GO:0060384) |
| 0.4 | 4.6 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
| 0.4 | 1.8 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.4 | 1.1 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
| 0.3 | 4.2 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.3 | 1.0 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
| 0.3 | 5.8 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.3 | 3.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
| 0.3 | 3.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
| 0.3 | 5.0 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.3 | 4.0 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.3 | 9.7 | GO:0071800 | podosome assembly(GO:0071800) |
| 0.3 | 1.0 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
| 0.3 | 3.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.3 | 7.6 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.3 | 1.0 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
| 0.3 | 2.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.3 | 1.3 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
| 0.3 | 4.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.3 | 7.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
| 0.3 | 1.6 | GO:0021650 | vestibulocochlear nerve morphogenesis(GO:0021648) vestibulocochlear nerve formation(GO:0021650) |
| 0.3 | 0.6 | GO:0038110 | interleukin-2-mediated signaling pathway(GO:0038110) |
| 0.3 | 1.0 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
| 0.3 | 0.6 | GO:0048850 | hypophysis morphogenesis(GO:0048850) diencephalon morphogenesis(GO:0048852) |
| 0.3 | 1.9 | GO:0071105 | response to interleukin-11(GO:0071105) |
| 0.3 | 2.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
| 0.3 | 1.9 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.3 | 1.0 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.3 | 1.0 | GO:0032252 | secretory granule localization(GO:0032252) |
| 0.3 | 7.6 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.3 | 1.3 | GO:1990502 | dense core granule maturation(GO:1990502) |
| 0.3 | 4.1 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.3 | 2.2 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.3 | 1.9 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 5.7 | GO:0048820 | hair follicle maturation(GO:0048820) |
| 0.3 | 11.3 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
| 0.3 | 2.5 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
| 0.3 | 4.7 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
| 0.3 | 1.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.3 | 2.2 | GO:0002158 | osteoclast proliferation(GO:0002158) |
| 0.3 | 1.8 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
| 0.3 | 1.8 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
| 0.3 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
| 0.3 | 1.2 | GO:0070092 | regulation of glucagon secretion(GO:0070092) |
| 0.3 | 4.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
| 0.3 | 1.8 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.3 | 2.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.3 | 0.6 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
| 0.3 | 1.2 | GO:1900104 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.3 | 5.8 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.3 | 5.5 | GO:0006068 | ethanol catabolic process(GO:0006068) |
| 0.3 | 2.0 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
| 0.3 | 1.2 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
| 0.3 | 2.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
| 0.3 | 2.0 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.3 | 3.1 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
| 0.3 | 2.0 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.3 | 3.1 | GO:0051014 | actin filament severing(GO:0051014) |
| 0.3 | 2.0 | GO:0015747 | urate transport(GO:0015747) |
| 0.3 | 0.8 | GO:0050893 | sensory processing(GO:0050893) |
| 0.3 | 0.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.3 | 0.6 | GO:1900191 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
| 0.3 | 2.3 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
| 0.3 | 0.6 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
| 0.3 | 5.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.3 | 0.8 | GO:0050957 | equilibrioception(GO:0050957) |
| 0.3 | 3.3 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
| 0.3 | 1.6 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
| 0.3 | 0.8 | GO:0036079 | GDP-fucose transport(GO:0015783) purine nucleotide-sugar transport(GO:0036079) |
| 0.3 | 0.5 | GO:0051295 | establishment of meiotic spindle localization(GO:0051295) |
| 0.3 | 1.1 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
| 0.3 | 3.2 | GO:1990118 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
| 0.3 | 2.4 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
| 0.3 | 1.3 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
| 0.3 | 0.5 | GO:0032714 | negative regulation of interleukin-5 production(GO:0032714) |
| 0.3 | 6.5 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
| 0.3 | 5.2 | GO:0042749 | regulation of circadian sleep/wake cycle(GO:0042749) regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
| 0.3 | 0.8 | GO:2000296 | regulation of hydrogen peroxide catabolic process(GO:2000295) negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
| 0.3 | 2.8 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.3 | 1.0 | GO:0002384 | hepatic immune response(GO:0002384) |
| 0.3 | 0.8 | GO:0042377 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
| 0.3 | 1.5 | GO:0031053 | primary miRNA processing(GO:0031053) |
| 0.3 | 2.3 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
| 0.3 | 8.3 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.3 | 2.8 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.2 | 0.7 | GO:0003228 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
| 0.2 | 2.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.2 | 2.7 | GO:0015871 | choline transport(GO:0015871) |
| 0.2 | 1.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.2 | 3.6 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.2 | 1.9 | GO:0061709 | reticulophagy(GO:0061709) |
| 0.2 | 1.7 | GO:0002767 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
| 0.2 | 1.7 | GO:0080009 | mRNA methylation(GO:0080009) |
| 0.2 | 4.5 | GO:0032228 | regulation of synaptic transmission, GABAergic(GO:0032228) |
| 0.2 | 0.7 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
| 0.2 | 0.5 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.2 | 2.1 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
| 0.2 | 8.0 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.2 | 0.7 | GO:0015942 | formate metabolic process(GO:0015942) |
| 0.2 | 2.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
| 0.2 | 1.6 | GO:1904100 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
| 0.2 | 3.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.2 | 2.7 | GO:0006828 | manganese ion transport(GO:0006828) |
| 0.2 | 3.1 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
| 0.2 | 1.3 | GO:0033274 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
| 0.2 | 3.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
| 0.2 | 1.5 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.2 | 0.4 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.2 | 3.2 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 11.1 | GO:0042073 | intraciliary transport(GO:0042073) |
| 0.2 | 0.6 | GO:0035564 | regulation of kidney size(GO:0035564) regulation of pronephros size(GO:0035565) |
| 0.2 | 1.0 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
| 0.2 | 1.2 | GO:0071600 | otic vesicle formation(GO:0030916) otic vesicle morphogenesis(GO:0071600) |
| 0.2 | 1.8 | GO:0042448 | progesterone metabolic process(GO:0042448) |
| 0.2 | 2.6 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
| 0.2 | 1.2 | GO:0060174 | limb bud formation(GO:0060174) |
| 0.2 | 2.2 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
| 0.2 | 2.2 | GO:0006011 | UDP-glucose metabolic process(GO:0006011) |
| 0.2 | 0.6 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
| 0.2 | 1.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
| 0.2 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
| 0.2 | 1.2 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
| 0.2 | 0.6 | GO:0001927 | exocyst assembly(GO:0001927) |
| 0.2 | 4.1 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
| 0.2 | 3.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
| 0.2 | 0.6 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.2 | 0.6 | GO:0045627 | positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.2 | 1.1 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 | 0.9 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 2.2 | GO:0042572 | retinol metabolic process(GO:0042572) |
| 0.2 | 1.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.2 | 2.4 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.2 | 2.4 | GO:0016075 | rRNA catabolic process(GO:0016075) |
| 0.2 | 0.6 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
| 0.2 | 1.7 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 5.7 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.2 | 2.4 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.2 | 0.9 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) dermatan sulfate proteoglycan metabolic process(GO:0050655) |
| 0.2 | 0.7 | GO:0034344 | type III interferon production(GO:0034343) regulation of type III interferon production(GO:0034344) |
| 0.2 | 0.5 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) abortive mitotic cell cycle(GO:0033277) |
| 0.2 | 0.4 | GO:0007500 | mesodermal cell fate determination(GO:0007500) |
| 0.2 | 0.5 | GO:0006566 | threonine metabolic process(GO:0006566) |
| 0.2 | 0.5 | GO:1902947 | regulation of tau-protein kinase activity(GO:1902947) |
| 0.2 | 1.1 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.2 | 1.2 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
| 0.2 | 8.1 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
| 0.2 | 2.8 | GO:0051281 | positive regulation of release of sequestered calcium ion into cytosol(GO:0051281) |
| 0.2 | 1.1 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.2 | 2.4 | GO:0070977 | bone maturation(GO:0070977) |
| 0.2 | 1.7 | GO:0072520 | seminiferous tubule development(GO:0072520) |
| 0.2 | 7.4 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.2 | 1.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 4.8 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
| 0.2 | 2.2 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.2 | 1.7 | GO:0060737 | prostate epithelial cord elongation(GO:0060523) prostate gland morphogenetic growth(GO:0060737) |
| 0.2 | 1.7 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
| 0.2 | 1.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.2 | 0.7 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 0.7 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
| 0.2 | 0.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
| 0.2 | 2.6 | GO:1905038 | regulation of sphingolipid biosynthetic process(GO:0090153) regulation of membrane lipid metabolic process(GO:1905038) regulation of ceramide biosynthetic process(GO:2000303) |
| 0.2 | 1.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.2 | 2.9 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 4.3 | GO:0006482 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.2 | 0.8 | GO:0048843 | negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.2 | 16.1 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
| 0.2 | 0.8 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.2 | 2.5 | GO:0003374 | dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 0.2 | 2.5 | GO:0006525 | arginine metabolic process(GO:0006525) |
| 0.2 | 0.9 | GO:0006540 | glutamate decarboxylation to succinate(GO:0006540) |
| 0.2 | 1.4 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.2 | 11.9 | GO:0042102 | positive regulation of T cell proliferation(GO:0042102) |
| 0.2 | 2.3 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
| 0.2 | 3.4 | GO:0097503 | sialylation(GO:0097503) |
| 0.2 | 0.2 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
| 0.2 | 0.6 | GO:0010900 | negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.2 | 5.0 | GO:0007271 | synaptic transmission, cholinergic(GO:0007271) |
| 0.2 | 0.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
| 0.2 | 0.8 | GO:0086073 | bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.2 | 0.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.2 | 1.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
| 0.1 | 1.6 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
| 0.1 | 1.2 | GO:0060122 | inner ear receptor stereocilium organization(GO:0060122) |
| 0.1 | 3.3 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.1 | 1.2 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.4 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.1 | 1.6 | GO:0045821 | positive regulation of glycolytic process(GO:0045821) |
| 0.1 | 2.4 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.1 | 0.4 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.1 | 2.4 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) |
| 0.1 | 4.7 | GO:0030317 | sperm motility(GO:0030317) |
| 0.1 | 4.8 | GO:0007588 | excretion(GO:0007588) |
| 0.1 | 0.7 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
| 0.1 | 0.4 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
| 0.1 | 1.0 | GO:1903273 | regulation of sodium ion export(GO:1903273) positive regulation of sodium ion export(GO:1903275) regulation of sodium ion export from cell(GO:1903276) positive regulation of sodium ion export from cell(GO:1903278) |
| 0.1 | 3.0 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.4 | GO:0060003 | copper ion export(GO:0060003) |
| 0.1 | 5.3 | GO:0018149 | peptide cross-linking(GO:0018149) |
| 0.1 | 1.9 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.1 | 0.4 | GO:0035509 | negative regulation of myosin-light-chain-phosphatase activity(GO:0035509) |
| 0.1 | 2.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
| 0.1 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
| 0.1 | 2.2 | GO:0006071 | glycerol metabolic process(GO:0006071) |
| 0.1 | 0.4 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 6.2 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.1 | 0.5 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
| 0.1 | 1.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 3.5 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
| 0.1 | 0.6 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
| 0.1 | 1.6 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 | 1.9 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.1 | 0.6 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
| 0.1 | 1.0 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 1.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 2.2 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
| 0.1 | 1.1 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
| 0.1 | 2.1 | GO:0070988 | demethylation(GO:0070988) |
| 0.1 | 1.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 1.7 | GO:0042755 | eating behavior(GO:0042755) |
| 0.1 | 12.3 | GO:0007286 | spermatid development(GO:0007286) |
| 0.1 | 0.4 | GO:0033168 | conversion of ds siRNA to ss siRNA involved in RNA interference(GO:0033168) conversion of ds siRNA to ss siRNA(GO:0036404) |
| 0.1 | 1.1 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
| 0.1 | 0.5 | GO:0000012 | single strand break repair(GO:0000012) |
| 0.1 | 1.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
| 0.1 | 1.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
| 0.1 | 3.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
| 0.1 | 1.0 | GO:0006591 | ornithine metabolic process(GO:0006591) |
| 0.1 | 2.5 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.1 | 0.4 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
| 0.1 | 1.5 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
| 0.1 | 1.3 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
| 0.1 | 1.4 | GO:0070914 | UV-damage excision repair(GO:0070914) |
| 0.1 | 1.5 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
| 0.1 | 9.9 | GO:1902476 | chloride transmembrane transport(GO:1902476) |
| 0.1 | 2.0 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
| 0.1 | 1.6 | GO:0010918 | positive regulation of mitochondrial membrane potential(GO:0010918) |
| 0.1 | 0.6 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
| 0.1 | 1.1 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.1 | 1.0 | GO:0032329 | serine transport(GO:0032329) |
| 0.1 | 1.3 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
| 0.1 | 5.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.1 | 0.9 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
| 0.1 | 1.7 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
| 0.1 | 1.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
| 0.1 | 0.5 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 | 1.2 | GO:0030238 | male sex determination(GO:0030238) |
| 0.1 | 0.3 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 | 1.7 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.1 | 1.8 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
| 0.1 | 0.3 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
| 0.1 | 3.2 | GO:0097120 | receptor localization to synapse(GO:0097120) |
| 0.1 | 0.4 | GO:0061107 | seminal vesicle development(GO:0061107) |
| 0.1 | 0.6 | GO:1990034 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
| 0.1 | 1.8 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
| 0.1 | 3.7 | GO:0019228 | neuronal action potential(GO:0019228) |
| 0.1 | 5.5 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
| 0.1 | 1.4 | GO:1903817 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.1 | 0.6 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.1 | 3.2 | GO:0009584 | detection of visible light(GO:0009584) |
| 0.1 | 0.7 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 3.5 | GO:0010107 | potassium ion import(GO:0010107) |
| 0.1 | 0.2 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
| 0.1 | 0.2 | GO:1902358 | sulfate transmembrane transport(GO:1902358) |
| 0.1 | 0.8 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
| 0.1 | 0.7 | GO:0070995 | NADPH oxidation(GO:0070995) |
| 0.1 | 1.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.1 | 1.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.1 | 0.5 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
| 0.1 | 1.7 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.1 | 21.6 | GO:0002250 | adaptive immune response(GO:0002250) |
| 0.1 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
| 0.1 | 0.9 | GO:0001975 | response to amphetamine(GO:0001975) |
| 0.1 | 2.9 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
| 0.1 | 0.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 | 1.3 | GO:0090360 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.1 | 3.6 | GO:0051703 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.1 | 0.5 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.1 | 0.2 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
| 0.1 | 0.9 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
| 0.1 | 3.6 | GO:0046847 | filopodium assembly(GO:0046847) |
| 0.1 | 4.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
| 0.1 | 0.7 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.1 | 1.8 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
| 0.1 | 1.5 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.1 | 2.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
| 0.1 | 9.3 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
| 0.1 | 1.6 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.1 | 2.6 | GO:0008306 | associative learning(GO:0008306) |
| 0.1 | 0.3 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
| 0.1 | 0.3 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
| 0.1 | 1.2 | GO:0001502 | cartilage condensation(GO:0001502) |
| 0.1 | 1.0 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 1.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.1 | 0.5 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
| 0.1 | 0.9 | GO:0042634 | regulation of hair cycle(GO:0042634) |
| 0.1 | 0.2 | GO:0042447 | hormone catabolic process(GO:0042447) |
| 0.1 | 5.7 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
| 0.1 | 2.8 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
| 0.1 | 3.1 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.1 | 0.4 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.1 | 0.7 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.1 | 0.5 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.1 | 2.3 | GO:0050918 | positive chemotaxis(GO:0050918) |
| 0.1 | 0.3 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
| 0.1 | 1.7 | GO:0009083 | branched-chain amino acid metabolic process(GO:0009081) branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 8.1 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.1 | 1.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.1 | 2.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
| 0.1 | 1.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 | 0.9 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
| 0.1 | 0.9 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
| 0.1 | 0.5 | GO:0030818 | negative regulation of cAMP biosynthetic process(GO:0030818) |
| 0.1 | 0.9 | GO:0042220 | response to cocaine(GO:0042220) |
| 0.0 | 0.4 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 0.0 | 1.2 | GO:0046326 | positive regulation of glucose transport(GO:0010828) positive regulation of glucose import(GO:0046326) |
| 0.0 | 0.5 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.0 | 0.6 | GO:0006590 | thyroid hormone generation(GO:0006590) |
| 0.0 | 1.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.0 | 0.5 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
| 0.0 | 2.4 | GO:0050709 | negative regulation of protein secretion(GO:0050709) |
| 0.0 | 1.9 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
| 0.0 | 0.1 | GO:0002159 | desmosome assembly(GO:0002159) |
| 0.0 | 0.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
| 0.0 | 1.3 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 1.8 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.0 | 0.5 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
| 0.0 | 0.5 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 | 2.1 | GO:0006835 | dicarboxylic acid transport(GO:0006835) |
| 0.0 | 0.2 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.0 | 1.6 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 | 0.5 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.0 | 0.7 | GO:0070536 | protein K63-linked deubiquitination(GO:0070536) |
| 0.0 | 1.4 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
| 0.0 | 0.7 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 | 0.9 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
| 0.0 | 0.4 | GO:0030318 | melanocyte differentiation(GO:0030318) |
| 0.0 | 0.2 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
| 0.0 | 0.6 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
| 0.0 | 0.3 | GO:0031646 | positive regulation of myelination(GO:0031643) positive regulation of neurological system process(GO:0031646) |
| 0.0 | 0.8 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 | 0.4 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.0 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
| 0.0 | 0.2 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.1 | GO:0032695 | negative regulation of interleukin-12 production(GO:0032695) |
| 0.0 | 1.1 | GO:0035914 | skeletal muscle cell differentiation(GO:0035914) |
| 0.0 | 0.2 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
| 0.0 | 0.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
| 0.0 | 0.2 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
| 0.0 | 0.3 | GO:0060561 | apoptotic process involved in morphogenesis(GO:0060561) apoptotic process involved in development(GO:1902742) |
| 0.0 | 0.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
| 0.0 | 0.4 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 1.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
| 0.0 | 0.2 | GO:0098789 | mRNA cleavage involved in mRNA processing(GO:0098787) pre-mRNA cleavage required for polyadenylation(GO:0098789) |
| 0.0 | 0.3 | GO:0051788 | response to misfolded protein(GO:0051788) cellular response to misfolded protein(GO:0071218) |
| 0.0 | 0.1 | GO:1900426 | positive regulation of defense response to bacterium(GO:1900426) |
| 0.0 | 0.2 | GO:0021904 | dorsal/ventral neural tube patterning(GO:0021904) |
Gene overrepresentation in cellular component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.3 | 25.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
| 4.5 | 13.6 | GO:0071752 | dimeric IgA immunoglobulin complex(GO:0071750) secretory dimeric IgA immunoglobulin complex(GO:0071752) |
| 3.5 | 7.0 | GO:0071756 | IgM immunoglobulin complex(GO:0071753) IgM immunoglobulin complex, circulating(GO:0071754) pentameric IgM immunoglobulin complex(GO:0071756) |
| 2.8 | 8.4 | GO:0005760 | gamma DNA polymerase complex(GO:0005760) |
| 2.4 | 7.1 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
| 2.4 | 21.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 2.3 | 11.4 | GO:0036128 | CatSper complex(GO:0036128) |
| 1.9 | 91.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
| 1.8 | 5.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 1.7 | 25.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
| 1.5 | 7.3 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
| 1.2 | 5.9 | GO:0019815 | B cell receptor complex(GO:0019815) |
| 1.1 | 6.7 | GO:0071797 | LUBAC complex(GO:0071797) |
| 1.1 | 11.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
| 1.1 | 5.3 | GO:0044305 | calyx of Held(GO:0044305) |
| 1.1 | 3.2 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
| 1.0 | 7.3 | GO:1990745 | EARP complex(GO:1990745) |
| 1.0 | 1.0 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.9 | 3.8 | GO:0005602 | complement component C1 complex(GO:0005602) |
| 0.9 | 4.6 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.9 | 2.6 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.8 | 8.0 | GO:0071439 | clathrin complex(GO:0071439) |
| 0.8 | 26.2 | GO:0044298 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
| 0.8 | 3.0 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
| 0.7 | 3.0 | GO:1990879 | CST complex(GO:1990879) |
| 0.7 | 8.1 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.7 | 3.6 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.7 | 2.9 | GO:0035363 | histone locus body(GO:0035363) |
| 0.7 | 6.4 | GO:0032010 | phagolysosome(GO:0032010) |
| 0.7 | 4.2 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
| 0.7 | 2.8 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.7 | 3.9 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
| 0.6 | 11.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 0.6 | 7.4 | GO:0016013 | syntrophin complex(GO:0016013) |
| 0.6 | 5.3 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.6 | 4.6 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.6 | 5.6 | GO:0043203 | axon hillock(GO:0043203) |
| 0.6 | 2.8 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.6 | 12.2 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.5 | 9.9 | GO:0005922 | connexon complex(GO:0005922) |
| 0.5 | 2.7 | GO:0001652 | granular component(GO:0001652) |
| 0.5 | 3.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.5 | 2.7 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
| 0.5 | 6.5 | GO:0070938 | contractile ring(GO:0070938) |
| 0.5 | 9.0 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
| 0.5 | 12.8 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
| 0.5 | 3.9 | GO:0030430 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
| 0.5 | 0.5 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
| 0.5 | 10.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.5 | 3.3 | GO:0035976 | AP1 complex(GO:0035976) |
| 0.5 | 1.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
| 0.5 | 2.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.5 | 4.2 | GO:0001520 | outer dense fiber(GO:0001520) |
| 0.5 | 9.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
| 0.5 | 1.8 | GO:0000801 | central element(GO:0000801) |
| 0.5 | 6.8 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
| 0.5 | 1.8 | GO:0032009 | early phagosome(GO:0032009) |
| 0.5 | 17.3 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.5 | 3.6 | GO:0042575 | DNA polymerase complex(GO:0042575) |
| 0.5 | 3.6 | GO:0097433 | dense body(GO:0097433) |
| 0.5 | 1.8 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.4 | 2.7 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
| 0.4 | 2.6 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
| 0.4 | 2.1 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
| 0.4 | 4.2 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
| 0.4 | 3.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.4 | 1.2 | GO:0031085 | BLOC-3 complex(GO:0031085) |
| 0.4 | 2.0 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.4 | 2.4 | GO:1990357 | terminal web(GO:1990357) |
| 0.4 | 4.0 | GO:0045180 | basal cortex(GO:0045180) |
| 0.4 | 3.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
| 0.4 | 2.3 | GO:0002177 | manchette(GO:0002177) |
| 0.4 | 3.8 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.4 | 3.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
| 0.4 | 1.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.4 | 7.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.4 | 1.5 | GO:0000818 | nuclear MIS12/MIND complex(GO:0000818) |
| 0.4 | 1.8 | GO:0005921 | gap junction(GO:0005921) |
| 0.4 | 2.1 | GO:0032279 | asymmetric synapse(GO:0032279) |
| 0.4 | 3.9 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.3 | 2.4 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.3 | 5.9 | GO:0044613 | nuclear pore central transport channel(GO:0044613) nuclear pore nuclear basket(GO:0044615) |
| 0.3 | 1.7 | GO:0045160 | myosin I complex(GO:0045160) |
| 0.3 | 7.9 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
| 0.3 | 1.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
| 0.3 | 5.6 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.3 | 1.3 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.3 | 1.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
| 0.3 | 1.0 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.3 | 1.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
| 0.3 | 4.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.3 | 2.5 | GO:0097208 | alveolar lamellar body(GO:0097208) |
| 0.3 | 19.5 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
| 0.3 | 27.0 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.3 | 5.9 | GO:0016342 | catenin complex(GO:0016342) |
| 0.3 | 1.8 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.3 | 4.1 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.3 | 9.9 | GO:0000795 | synaptonemal complex(GO:0000795) |
| 0.3 | 2.3 | GO:0034464 | BBSome(GO:0034464) |
| 0.3 | 4.0 | GO:0070531 | BRCA1-A complex(GO:0070531) |
| 0.3 | 1.1 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
| 0.3 | 3.1 | GO:0031045 | dense core granule(GO:0031045) |
| 0.3 | 3.3 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.3 | 1.6 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
| 0.3 | 3.0 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.3 | 1.1 | GO:0070695 | FHF complex(GO:0070695) |
| 0.3 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
| 0.3 | 0.8 | GO:0000799 | nuclear condensin complex(GO:0000799) |
| 0.3 | 2.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
| 0.3 | 1.8 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
| 0.3 | 1.5 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.3 | 1.0 | GO:0070083 | clathrin-sculpted monoamine transport vesicle(GO:0070081) clathrin-sculpted monoamine transport vesicle membrane(GO:0070083) |
| 0.3 | 15.5 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 3.0 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
| 0.2 | 3.0 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.2 | 6.4 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 3.9 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.2 | 1.0 | GO:0044218 | other organism cell membrane(GO:0044218) other organism membrane(GO:0044279) |
| 0.2 | 3.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.2 | 3.0 | GO:0042599 | lamellar body(GO:0042599) |
| 0.2 | 1.8 | GO:0070187 | telosome(GO:0070187) |
| 0.2 | 1.6 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.2 | 6.3 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
| 0.2 | 23.9 | GO:0005796 | Golgi lumen(GO:0005796) |
| 0.2 | 1.9 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
| 0.2 | 1.9 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.2 | 1.0 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.2 | 3.0 | GO:0097546 | ciliary base(GO:0097546) |
| 0.2 | 5.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.2 | 31.7 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.2 | 2.5 | GO:0005589 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
| 0.2 | 3.7 | GO:0036038 | MKS complex(GO:0036038) |
| 0.2 | 26.4 | GO:0034705 | voltage-gated potassium channel complex(GO:0008076) potassium channel complex(GO:0034705) |
| 0.2 | 3.8 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.2 | 13.7 | GO:0005930 | axoneme(GO:0005930) ciliary plasm(GO:0097014) |
| 0.2 | 3.7 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
| 0.2 | 0.5 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
| 0.2 | 2.5 | GO:0031616 | spindle pole centrosome(GO:0031616) |
| 0.2 | 4.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 0.5 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
| 0.2 | 2.5 | GO:0097386 | glial cell projection(GO:0097386) |
| 0.2 | 1.8 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.2 | 0.8 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.2 | 7.9 | GO:0036064 | ciliary basal body(GO:0036064) |
| 0.2 | 4.2 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
| 0.1 | 1.2 | GO:0005587 | collagen type IV trimer(GO:0005587) |
| 0.1 | 4.8 | GO:0034451 | centriolar satellite(GO:0034451) |
| 0.1 | 1.5 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 0.7 | GO:1990425 | ryanodine receptor complex(GO:1990425) |
| 0.1 | 11.0 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 7.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.7 | GO:0060171 | stereocilium membrane(GO:0060171) |
| 0.1 | 0.8 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 1.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.1 | 1.2 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 1.5 | GO:0044666 | MLL3/4 complex(GO:0044666) |
| 0.1 | 2.4 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
| 0.1 | 0.5 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
| 0.1 | 6.1 | GO:0002102 | podosome(GO:0002102) |
| 0.1 | 0.4 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.1 | 1.6 | GO:0043083 | synaptic cleft(GO:0043083) |
| 0.1 | 4.5 | GO:0008305 | integrin complex(GO:0008305) |
| 0.1 | 0.4 | GO:0097636 | intrinsic component of autophagosome membrane(GO:0097636) integral component of autophagosome membrane(GO:0097637) |
| 0.1 | 1.5 | GO:0005883 | neurofilament(GO:0005883) |
| 0.1 | 0.5 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
| 0.1 | 0.4 | GO:0033167 | ARC complex(GO:0033167) |
| 0.1 | 17.6 | GO:0032587 | ruffle membrane(GO:0032587) |
| 0.1 | 0.4 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.1 | 8.6 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.1 | 1.3 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.1 | 0.4 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
| 0.1 | 0.6 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 0.1 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.1 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.1 | 0.7 | GO:0097486 | multivesicular body lumen(GO:0097486) |
| 0.1 | 5.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
| 0.1 | 4.1 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 1.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
| 0.1 | 6.5 | GO:0031514 | motile cilium(GO:0031514) |
| 0.1 | 0.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.1 | 5.3 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
| 0.1 | 0.6 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
| 0.1 | 0.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.1 | 0.7 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.1 | 3.7 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 0.4 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.1 | 1.9 | GO:0032590 | dendrite membrane(GO:0032590) |
| 0.1 | 1.4 | GO:0000786 | nucleosome(GO:0000786) |
| 0.1 | 3.3 | GO:0016459 | myosin complex(GO:0016459) |
| 0.1 | 2.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 1.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
| 0.1 | 0.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.1 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
| 0.1 | 17.9 | GO:0098793 | presynapse(GO:0098793) |
| 0.1 | 0.5 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
| 0.1 | 7.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
| 0.1 | 0.8 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.0 | 0.1 | GO:0005606 | laminin-1 complex(GO:0005606) |
| 0.0 | 0.3 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
| 0.0 | 0.2 | GO:0032449 | CBM complex(GO:0032449) |
| 0.0 | 1.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.0 | 3.1 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
| 0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
| 0.0 | 0.7 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
| 0.0 | 2.0 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.0 | 0.7 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
| 0.0 | 0.4 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.0 | 1.8 | GO:0034702 | ion channel complex(GO:0034702) |
| 0.0 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.0 | 3.8 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.4 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.0 | 0.4 | GO:0031082 | BLOC complex(GO:0031082) |
| 0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
| 0.0 | 1.0 | GO:0031594 | neuromuscular junction(GO:0031594) |
| 0.0 | 4.7 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.0 | 0.6 | GO:0043679 | axon terminus(GO:0043679) |
| 0.0 | 8.7 | GO:0045177 | apical part of cell(GO:0045177) |
| 0.0 | 0.2 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.0 | 0.3 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.0 | 4.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
| 0.0 | 1.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
Gene overrepresentation in molecular function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 6.8 | 20.3 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 3.8 | 15.0 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
| 3.1 | 9.3 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
| 3.0 | 9.1 | GO:0004877 | complement component C4b receptor activity(GO:0001861) complement component C3b receptor activity(GO:0004877) |
| 2.7 | 10.8 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
| 2.6 | 13.1 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
| 2.5 | 22.9 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 2.2 | 6.7 | GO:0031493 | nucleosomal histone binding(GO:0031493) SAM domain binding(GO:0032093) |
| 2.2 | 4.4 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 2.0 | 5.9 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
| 1.9 | 5.7 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
| 1.9 | 113.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 1.8 | 5.5 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 1.8 | 7.1 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
| 1.7 | 25.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 1.7 | 5.0 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
| 1.7 | 6.7 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 1.7 | 8.4 | GO:0016890 | site-specific endodeoxyribonuclease activity, specific for altered base(GO:0016890) |
| 1.5 | 4.5 | GO:0004912 | interleukin-3 receptor activity(GO:0004912) |
| 1.5 | 4.4 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
| 1.4 | 5.7 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
| 1.4 | 5.7 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
| 1.4 | 6.8 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
| 1.3 | 4.0 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
| 1.3 | 5.3 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 1.3 | 6.3 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 1.2 | 3.7 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 1.2 | 3.7 | GO:0015389 | pyrimidine- and adenine-specific:sodium symporter activity(GO:0015389) |
| 1.2 | 3.5 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
| 1.2 | 15.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 1.2 | 2.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
| 1.1 | 3.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
| 1.1 | 6.7 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
| 1.1 | 5.5 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 1.1 | 3.3 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
| 1.1 | 5.4 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 1.0 | 6.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 1.0 | 4.1 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
| 1.0 | 7.2 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
| 1.0 | 5.1 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
| 1.0 | 3.9 | GO:0016211 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
| 1.0 | 6.9 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
| 1.0 | 2.9 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 1.0 | 8.7 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.9 | 4.7 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
| 0.9 | 7.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
| 0.9 | 2.7 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
| 0.9 | 4.6 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.9 | 6.4 | GO:0034594 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity(GO:0034485) phosphatidylinositol trisphosphate phosphatase activity(GO:0034594) |
| 0.9 | 4.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
| 0.9 | 9.9 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.9 | 57.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
| 0.9 | 2.6 | GO:0047783 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
| 0.9 | 2.6 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
| 0.8 | 4.2 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
| 0.8 | 4.2 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
| 0.8 | 8.3 | GO:0031013 | troponin I binding(GO:0031013) |
| 0.8 | 27.7 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
| 0.8 | 4.1 | GO:0008410 | CoA-transferase activity(GO:0008410) |
| 0.8 | 7.1 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
| 0.8 | 7.1 | GO:0089720 | caspase binding(GO:0089720) |
| 0.8 | 2.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
| 0.8 | 4.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
| 0.8 | 17.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
| 0.8 | 10.7 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
| 0.7 | 5.2 | GO:0086089 | voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization(GO:0086089) |
| 0.7 | 3.7 | GO:0004945 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
| 0.7 | 2.2 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
| 0.7 | 3.6 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.7 | 13.5 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
| 0.7 | 2.8 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
| 0.7 | 6.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
| 0.7 | 11.0 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.7 | 5.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
| 0.7 | 3.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
| 0.7 | 6.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.7 | 5.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
| 0.7 | 8.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.7 | 2.0 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.7 | 10.5 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 0.7 | 9.8 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
| 0.7 | 7.2 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.7 | 2.0 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
| 0.7 | 6.5 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
| 0.7 | 7.2 | GO:0008061 | chitinase activity(GO:0004568) chitin binding(GO:0008061) |
| 0.6 | 3.9 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
| 0.6 | 4.5 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
| 0.6 | 2.5 | GO:0004080 | biotin-[acetyl-CoA-carboxylase] ligase activity(GO:0004077) biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity(GO:0004078) biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity(GO:0004079) biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity(GO:0004080) biotin-protein ligase activity(GO:0018271) |
| 0.6 | 9.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.6 | 1.8 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
| 0.6 | 2.4 | GO:0004909 | interleukin-1, Type I, activating receptor activity(GO:0004909) |
| 0.6 | 1.7 | GO:0008431 | vitamin E binding(GO:0008431) |
| 0.6 | 2.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.6 | 2.3 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
| 0.6 | 8.6 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
| 0.6 | 5.1 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
| 0.6 | 1.7 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.6 | 2.3 | GO:0004360 | glutamine-fructose-6-phosphate transaminase (isomerizing) activity(GO:0004360) |
| 0.6 | 1.7 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
| 0.6 | 1.7 | GO:0016422 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
| 0.6 | 3.4 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
| 0.6 | 4.4 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
| 0.6 | 2.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
| 0.6 | 3.9 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.6 | 1.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
| 0.5 | 1.6 | GO:0045322 | unmethylated CpG binding(GO:0045322) |
| 0.5 | 11.3 | GO:0050811 | GABA receptor binding(GO:0050811) |
| 0.5 | 2.7 | GO:0004905 | type I interferon receptor activity(GO:0004905) |
| 0.5 | 5.2 | GO:0036310 | annealing helicase activity(GO:0036310) |
| 0.5 | 3.6 | GO:0050294 | steroid sulfotransferase activity(GO:0050294) |
| 0.5 | 2.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
| 0.5 | 7.1 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
| 0.5 | 2.0 | GO:0004341 | gluconolactonase activity(GO:0004341) |
| 0.5 | 1.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
| 0.5 | 1.5 | GO:0008511 | sodium:potassium:chloride symporter activity(GO:0008511) |
| 0.5 | 10.3 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.5 | 1.9 | GO:0004488 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.5 | 1.4 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
| 0.5 | 3.3 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
| 0.5 | 2.8 | GO:0005330 | dopamine:sodium symporter activity(GO:0005330) |
| 0.5 | 1.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.5 | 3.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.5 | 1.9 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
| 0.5 | 1.9 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.5 | 5.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
| 0.5 | 1.4 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
| 0.5 | 6.8 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.5 | 2.7 | GO:0039552 | RIG-I binding(GO:0039552) |
| 0.5 | 10.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.5 | 1.8 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.4 | 1.8 | GO:0004773 | steryl-sulfatase activity(GO:0004773) |
| 0.4 | 3.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
| 0.4 | 2.2 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
| 0.4 | 3.4 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.4 | 1.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) alpha-2C adrenergic receptor binding(GO:0031696) |
| 0.4 | 9.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.4 | 2.5 | GO:0070004 | cysteine-type carboxypeptidase activity(GO:0016807) cysteine-type exopeptidase activity(GO:0070004) |
| 0.4 | 5.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
| 0.4 | 3.3 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
| 0.4 | 0.4 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
| 0.4 | 8.9 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
| 0.4 | 2.0 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
| 0.4 | 8.7 | GO:0052629 | phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity(GO:0052629) |
| 0.4 | 6.8 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.4 | 1.2 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.4 | 14.6 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
| 0.4 | 2.8 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.4 | 1.6 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
| 0.4 | 66.3 | GO:0003823 | antigen binding(GO:0003823) |
| 0.4 | 11.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
| 0.4 | 7.3 | GO:0045294 | alpha-catenin binding(GO:0045294) |
| 0.4 | 1.9 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
| 0.4 | 3.1 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
| 0.4 | 1.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
| 0.4 | 2.6 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
| 0.4 | 3.7 | GO:0008430 | selenium binding(GO:0008430) |
| 0.4 | 1.1 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
| 0.4 | 4.5 | GO:0070411 | I-SMAD binding(GO:0070411) |
| 0.4 | 1.1 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
| 0.4 | 1.9 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
| 0.4 | 4.1 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.4 | 1.1 | GO:0036055 | protein-malonyllysine demalonylase activity(GO:0036054) protein-succinyllysine desuccinylase activity(GO:0036055) protein-glutaryllysine deglutarylase activity(GO:0061697) |
| 0.4 | 2.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
| 0.4 | 4.6 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
| 0.4 | 2.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.3 | 7.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 3.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.3 | 3.8 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.3 | 2.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
| 0.3 | 1.7 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
| 0.3 | 1.0 | GO:0070119 | ciliary neurotrophic factor binding(GO:0070119) |
| 0.3 | 4.1 | GO:0051378 | amine binding(GO:0043176) serotonin binding(GO:0051378) |
| 0.3 | 1.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
| 0.3 | 3.0 | GO:0043426 | MRF binding(GO:0043426) |
| 0.3 | 1.0 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
| 0.3 | 2.3 | GO:0031705 | bombesin receptor binding(GO:0031705) |
| 0.3 | 3.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
| 0.3 | 6.7 | GO:0005112 | Notch binding(GO:0005112) |
| 0.3 | 3.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
| 0.3 | 0.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 0.3 | 0.6 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
| 0.3 | 1.6 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
| 0.3 | 1.9 | GO:0004525 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
| 0.3 | 4.3 | GO:0003691 | double-stranded telomeric DNA binding(GO:0003691) |
| 0.3 | 5.9 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
| 0.3 | 0.9 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.3 | 3.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.3 | 3.1 | GO:0051525 | NFAT protein binding(GO:0051525) |
| 0.3 | 2.1 | GO:0001640 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
| 0.3 | 4.0 | GO:0031419 | cobalamin binding(GO:0031419) |
| 0.3 | 1.8 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) potassium ion antiporter activity(GO:0022821) |
| 0.3 | 15.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.3 | 3.0 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.3 | 5.7 | GO:0043274 | phospholipase binding(GO:0043274) |
| 0.3 | 2.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
| 0.3 | 2.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
| 0.3 | 1.2 | GO:0035243 | protein-arginine omega-N symmetric methyltransferase activity(GO:0035243) |
| 0.3 | 3.2 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.3 | 2.9 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
| 0.3 | 2.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.3 | 0.8 | GO:0048030 | disaccharide binding(GO:0048030) |
| 0.3 | 5.0 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.3 | 2.2 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
| 0.3 | 0.8 | GO:0030618 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity(GO:0030618) |
| 0.3 | 3.0 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
| 0.3 | 4.6 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 0.3 | 3.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.3 | 1.6 | GO:0015350 | reduced folate carrier activity(GO:0008518) methotrexate transporter activity(GO:0015350) |
| 0.3 | 1.9 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.3 | 1.6 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
| 0.3 | 0.8 | GO:0036080 | GDP-fucose transmembrane transporter activity(GO:0005457) purine nucleotide-sugar transmembrane transporter activity(GO:0036080) |
| 0.3 | 1.6 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
| 0.3 | 1.0 | GO:0022865 | transmembrane electron transfer carrier(GO:0022865) |
| 0.3 | 1.8 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
| 0.3 | 0.5 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.3 | 5.4 | GO:0001087 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
| 0.3 | 12.5 | GO:0019894 | kinesin binding(GO:0019894) |
| 0.3 | 1.0 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
| 0.3 | 2.3 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.2 | 3.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.2 | 11.4 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 2.2 | GO:0035251 | UDP-glucosyltransferase activity(GO:0035251) |
| 0.2 | 1.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
| 0.2 | 3.8 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.2 | 2.9 | GO:0015250 | water channel activity(GO:0015250) |
| 0.2 | 19.4 | GO:0004497 | monooxygenase activity(GO:0004497) |
| 0.2 | 1.2 | GO:0030109 | HLA-B specific inhibitory MHC class I receptor activity(GO:0030109) |
| 0.2 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.2 | 0.9 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.2 | 1.4 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
| 0.2 | 2.7 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.2 | 1.1 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
| 0.2 | 3.1 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
| 0.2 | 14.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
| 0.2 | 0.4 | GO:0035473 | lipase binding(GO:0035473) |
| 0.2 | 1.3 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 3.1 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
| 0.2 | 6.1 | GO:0043621 | protein self-association(GO:0043621) |
| 0.2 | 6.3 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) acetylcholine binding(GO:0042166) |
| 0.2 | 5.4 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
| 0.2 | 1.3 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 8.1 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.2 | 1.9 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.2 | 4.0 | GO:0031005 | filamin binding(GO:0031005) |
| 0.2 | 1.5 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 1.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.2 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.2 | 3.5 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
| 0.2 | 1.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
| 0.2 | 0.8 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
| 0.2 | 5.4 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
| 0.2 | 2.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 5.4 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
| 0.2 | 5.9 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.2 | 3.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.2 | 2.3 | GO:0038132 | neuregulin binding(GO:0038132) |
| 0.2 | 1.4 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
| 0.2 | 1.6 | GO:0031404 | chloride ion binding(GO:0031404) |
| 0.2 | 2.5 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
| 0.2 | 0.9 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.2 | 3.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.2 | 0.6 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
| 0.2 | 0.9 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.2 | 0.9 | GO:0001093 | TFIIB-class transcription factor binding(GO:0001093) |
| 0.2 | 0.6 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.2 | 1.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
| 0.2 | 9.4 | GO:0030507 | spectrin binding(GO:0030507) |
| 0.2 | 0.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.2 | 3.3 | GO:0005522 | profilin binding(GO:0005522) |
| 0.2 | 20.2 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
| 0.2 | 6.7 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.2 | 1.8 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
| 0.2 | 0.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) ethanol binding(GO:0035276) |
| 0.2 | 2.3 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 1.2 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.2 | 2.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
| 0.2 | 0.5 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
| 0.2 | 1.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.2 | 1.2 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.2 | 8.0 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.2 | 0.5 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.2 | 1.7 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
| 0.2 | 5.3 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.2 | 0.5 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.2 | 3.7 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.2 | 1.3 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.2 | 2.0 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
| 0.2 | 1.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.2 | 1.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.2 | 2.0 | GO:0022851 | GABA-gated chloride ion channel activity(GO:0022851) |
| 0.2 | 0.6 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) interleukin-2 binding(GO:0019976) |
| 0.2 | 3.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.2 | 16.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.2 | 2.7 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.2 | 9.5 | GO:0008080 | N-acetyltransferase activity(GO:0008080) |
| 0.2 | 0.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.2 | 0.5 | GO:0042020 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
| 0.2 | 1.4 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 0.5 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.2 | 0.5 | GO:0052796 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
| 0.2 | 3.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
| 0.1 | 1.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
| 0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 6.0 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.1 | 0.7 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.7 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 9.1 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.1 | 0.4 | GO:0043682 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
| 0.1 | 0.4 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.1 | 0.8 | GO:0070728 | leucine binding(GO:0070728) |
| 0.1 | 0.4 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
| 0.1 | 3.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.1 | 2.1 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
| 0.1 | 1.0 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.1 | 4.8 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
| 0.1 | 0.8 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
| 0.1 | 2.7 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0032427 | GBD domain binding(GO:0032427) |
| 0.1 | 4.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.1 | 0.5 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
| 0.1 | 2.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
| 0.1 | 1.1 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
| 0.1 | 1.5 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 4.9 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
| 0.1 | 4.4 | GO:0008009 | chemokine activity(GO:0008009) |
| 0.1 | 0.4 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
| 0.1 | 0.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.1 | 1.9 | GO:0001848 | complement binding(GO:0001848) |
| 0.1 | 11.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.1 | 1.8 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
| 0.1 | 1.9 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
| 0.1 | 15.5 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.6 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
| 0.1 | 2.0 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
| 0.1 | 0.5 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.4 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
| 0.1 | 0.6 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.1 | 1.6 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
| 0.1 | 2.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.1 | 3.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 0.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.1 | 1.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
| 0.1 | 2.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 4.3 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
| 0.1 | 2.7 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.1 | 1.2 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
| 0.1 | 0.7 | GO:0015232 | heme transporter activity(GO:0015232) |
| 0.1 | 0.8 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.1 | 0.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.4 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
| 0.1 | 0.5 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.1 | 0.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.1 | 5.0 | GO:0035004 | phosphatidylinositol 3-kinase activity(GO:0035004) |
| 0.1 | 2.2 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 1.9 | GO:0070840 | dynein complex binding(GO:0070840) |
| 0.1 | 2.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.1 | 1.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.1 | 2.0 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.1 | 0.8 | GO:0032393 | MHC class I receptor activity(GO:0032393) |
| 0.1 | 0.3 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.1 | 1.8 | GO:0015026 | coreceptor activity(GO:0015026) |
| 0.1 | 1.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 112.9 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 6.0 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.3 | GO:0047708 | biotinidase activity(GO:0047708) |
| 0.1 | 1.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
| 0.1 | 2.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.4 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.1 | 0.2 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.1 | 1.7 | GO:0005484 | SNAP receptor activity(GO:0005484) |
| 0.1 | 0.2 | GO:0031626 | beta-endorphin binding(GO:0031626) |
| 0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
| 0.1 | 0.3 | GO:0044736 | acid-sensing ion channel activity(GO:0044736) |
| 0.1 | 0.7 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
| 0.1 | 1.2 | GO:0015144 | carbohydrate transmembrane transporter activity(GO:0015144) carbohydrate transporter activity(GO:1901476) |
| 0.1 | 0.4 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
| 0.1 | 0.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
| 0.1 | 2.8 | GO:0004114 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) |
| 0.1 | 2.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
| 0.1 | 0.2 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 1.3 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
| 0.1 | 0.3 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
| 0.1 | 0.7 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.1 | 0.3 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
| 0.1 | 1.5 | GO:0004629 | phospholipase C activity(GO:0004629) |
| 0.1 | 1.5 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
| 0.1 | 0.8 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
| 0.1 | 0.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.0 | 0.1 | GO:0005549 | odorant binding(GO:0005549) |
| 0.0 | 3.7 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.0 | 2.9 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.0 | 1.8 | GO:0004385 | guanylate kinase activity(GO:0004385) |
| 0.0 | 0.4 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
| 0.0 | 0.2 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
| 0.0 | 1.4 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
| 0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.0 | 0.4 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
| 0.0 | 10.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.6 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.0 | 0.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.0 | 0.3 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.0 | 0.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
| 0.0 | 1.0 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
| 0.0 | 2.6 | GO:0005088 | Ras guanyl-nucleotide exchange factor activity(GO:0005088) |
| 0.0 | 1.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.0 | 1.0 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
| 0.0 | 0.3 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.0 | 0.2 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
| 0.0 | 9.0 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
| 0.0 | 0.2 | GO:0050733 | RS domain binding(GO:0050733) |
| 0.0 | 3.8 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.0 | 0.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
| 0.0 | 0.3 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.2 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
Gene overrepresentation in curated gene sets: canonical pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 4.5 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
| 0.7 | 4.9 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
| 0.7 | 15.2 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.4 | 3.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.4 | 3.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
| 0.4 | 7.2 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
| 0.4 | 3.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
| 0.4 | 3.2 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.3 | 9.8 | PID IL3 PATHWAY | IL3-mediated signaling events |
| 0.3 | 17.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.3 | 3.7 | PID RAC1 PATHWAY | RAC1 signaling pathway |
| 0.3 | 3.7 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.3 | 15.0 | PID IL12 STAT4 PATHWAY | IL12 signaling mediated by STAT4 |
| 0.3 | 30.7 | PID IL4 2PATHWAY | IL4-mediated signaling events |
| 0.3 | 11.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
| 0.3 | 9.6 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
| 0.3 | 8.7 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
| 0.3 | 17.8 | PID BCR 5PATHWAY | BCR signaling pathway |
| 0.3 | 47.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
| 0.2 | 3.1 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
| 0.2 | 3.8 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 8.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
| 0.2 | 1.7 | PID MYC PATHWAY | C-MYC pathway |
| 0.2 | 1.9 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
| 0.2 | 3.0 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
| 0.2 | 3.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
| 0.2 | 5.7 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
| 0.2 | 1.0 | ST STAT3 PATHWAY | STAT3 Pathway |
| 0.2 | 2.6 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
| 0.1 | 6.9 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 4.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
| 0.1 | 1.4 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
| 0.1 | 4.0 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
| 0.1 | 0.8 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.1 | 1.1 | PID ENDOTHELIN PATHWAY | Endothelins |
| 0.1 | 3.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.1 | 5.9 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
| 0.1 | 2.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 3.0 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
| 0.1 | 8.4 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
| 0.1 | 3.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 1.8 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
| 0.1 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
| 0.1 | 1.5 | PID EPHB FWD PATHWAY | EPHB forward signaling |
| 0.1 | 3.1 | PID IL1 PATHWAY | IL1-mediated signaling events |
| 0.1 | 5.7 | PID ATR PATHWAY | ATR signaling pathway |
| 0.1 | 7.3 | PID FGF PATHWAY | FGF signaling pathway |
| 0.1 | 0.4 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 3.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
| 0.1 | 2.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
| 0.1 | 3.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
| 0.1 | 2.5 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
| 0.1 | 1.1 | PID EPO PATHWAY | EPO signaling pathway |
| 0.1 | 4.0 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 2.0 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.1 | 1.4 | PID IL23 PATHWAY | IL23-mediated signaling events |
| 0.1 | 4.1 | PID BMP PATHWAY | BMP receptor signaling |
| 0.1 | 2.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
| 0.1 | 1.9 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| 0.1 | 3.5 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 2.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
| 0.1 | 2.9 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
| 0.0 | 0.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 0.5 | ST GA12 PATHWAY | G alpha 12 Pathway |
| 0.0 | 1.3 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
| 0.0 | 3.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.7 | PID ARF6 PATHWAY | Arf6 signaling events |
| 0.0 | 0.5 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
| 0.0 | 1.5 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
| 0.0 | 0.7 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
| 0.0 | 0.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
| 0.0 | 1.2 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
| 0.0 | 0.3 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.0 | 0.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.0 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
| 0.0 | 4.2 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.0 | 1.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
| 0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Gene overrepresentation in curated gene sets: REACTOME pathways category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.0 | 11.5 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
| 1.0 | 2.0 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.9 | 19.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
| 0.8 | 10.5 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
| 0.6 | 13.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
| 0.6 | 11.7 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
| 0.5 | 9.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
| 0.5 | 1.1 | REACTOME ACTIVATION OF THE PRE REPLICATIVE COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.5 | 9.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
| 0.5 | 11.0 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
| 0.5 | 7.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
| 0.5 | 3.9 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
| 0.5 | 1.9 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
| 0.4 | 7.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
| 0.4 | 6.2 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
| 0.4 | 8.7 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
| 0.4 | 4.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.4 | 3.2 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.4 | 4.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.4 | 4.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
| 0.3 | 8.0 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
| 0.3 | 6.1 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
| 0.3 | 151.0 | REACTOME GENERIC TRANSCRIPTION PATHWAY | Genes involved in Generic Transcription Pathway |
| 0.3 | 1.0 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
| 0.3 | 6.4 | REACTOME DEFENSINS | Genes involved in Defensins |
| 0.3 | 2.8 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
| 0.3 | 5.0 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.3 | 9.7 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
| 0.3 | 1.5 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
| 0.3 | 3.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
| 0.3 | 8.9 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
| 0.3 | 14.7 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
| 0.3 | 10.7 | REACTOME GABA A RECEPTOR ACTIVATION | Genes involved in GABA A receptor activation |
| 0.3 | 5.4 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
| 0.3 | 12.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.3 | 5.5 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.3 | 3.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
| 0.2 | 3.9 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
| 0.2 | 10.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
| 0.2 | 0.5 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 1.9 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.2 | 10.2 | REACTOME AMYLOIDS | Genes involved in Amyloids |
| 0.2 | 3.2 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
| 0.2 | 5.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
| 0.2 | 1.6 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.2 | 3.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 5.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
| 0.2 | 3.3 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
| 0.2 | 4.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
| 0.2 | 1.7 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
| 0.2 | 1.7 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
| 0.2 | 3.4 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
| 0.2 | 4.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
| 0.2 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
| 0.2 | 1.9 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
| 0.2 | 4.4 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
| 0.2 | 2.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.2 | 16.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
| 0.2 | 3.8 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
| 0.2 | 2.0 | REACTOME OPSINS | Genes involved in Opsins |
| 0.2 | 2.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
| 0.2 | 3.5 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
| 0.2 | 1.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
| 0.2 | 7.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 1.8 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
| 0.2 | 4.3 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
| 0.2 | 8.5 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
| 0.2 | 3.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 4.5 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
| 0.1 | 3.7 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
| 0.1 | 4.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.1 | 1.0 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
| 0.1 | 0.8 | REACTOME ACETYLCHOLINE BINDING AND DOWNSTREAM EVENTS | Genes involved in Acetylcholine Binding And Downstream Events |
| 0.1 | 1.3 | REACTOME ION CHANNEL TRANSPORT | Genes involved in Ion channel transport |
| 0.1 | 3.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
| 0.1 | 4.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.1 | 4.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
| 0.1 | 0.3 | REACTOME HIV INFECTION | Genes involved in HIV Infection |
| 0.1 | 0.4 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
| 0.1 | 2.9 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
| 0.1 | 3.9 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
| 0.1 | 9.8 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 3.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 3.3 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 1.8 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
| 0.1 | 3.0 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.1 | 2.4 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
| 0.1 | 6.2 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
| 0.1 | 0.8 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.1 | 2.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.1 | 6.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
| 0.1 | 0.9 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
| 0.1 | 2.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
| 0.1 | 4.1 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
| 0.1 | 1.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
| 0.1 | 0.6 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
| 0.1 | 2.0 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
| 0.1 | 4.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
| 0.1 | 2.1 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
| 0.1 | 2.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.1 | 1.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.1 | 1.7 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
| 0.1 | 12.4 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
| 0.1 | 2.8 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
| 0.1 | 1.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
| 0.1 | 18.1 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
| 0.1 | 6.5 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.1 | 4.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
| 0.1 | 2.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.1 | 0.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
| 0.1 | 4.1 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
| 0.1 | 4.8 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.1 | 4.5 | REACTOME CLASS A1 RHODOPSIN LIKE RECEPTORS | Genes involved in Class A/1 (Rhodopsin-like receptors) |
| 0.1 | 1.4 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
| 0.1 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
| 0.1 | 1.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
| 0.1 | 2.0 | REACTOME UNBLOCKING OF NMDA RECEPTOR GLUTAMATE BINDING AND ACTIVATION | Genes involved in Unblocking of NMDA receptor, glutamate binding and activation |
| 0.1 | 0.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
| 0.1 | 1.7 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
| 0.1 | 1.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
| 0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
| 0.0 | 1.2 | REACTOME CELL CELL JUNCTION ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.0 | 1.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.0 | 0.6 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.0 | 0.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
| 0.0 | 0.9 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.0 | 1.1 | REACTOME CHROMOSOME MAINTENANCE | Genes involved in Chromosome Maintenance |
| 0.0 | 0.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
| 0.0 | 0.4 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.0 | 0.5 | REACTOME NGF SIGNALLING VIA TRKA FROM THE PLASMA MEMBRANE | Genes involved in NGF signalling via TRKA from the plasma membrane |
| 0.0 | 0.4 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
| 0.0 | 0.2 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
| 0.0 | 0.6 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
| 0.0 | 0.7 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.0 | 0.3 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 1.3 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |